Moreover, the authors showed a positive correlation between JAM-A expression and poor prognosis of nasopharyngeal cancer patients, suggesting a therapeutic potential for inhibiting JAM-A in these patients [115]. Here, F11R is linked to nasopharyngeal carcinoma.